Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabel Spriet

Showing results (191-200 of 237) with videos related to

Pageof 24
Sort By:
Air Medical Journal|July 10, 2016
Stability of Drugs Used in Helicopter Air Medical Emergency Services: An Exploratory StudySabrina De Winter, Koen Bronselaer, Peter Vanbrabant, et al.
Mycoses|May 8, 2021
Concomitant use of isavuconazole and CYP3A4/5 inducers: Where pharmacogenetics meets pharmacokineticsRuth Van Daele, Yves Debaveye, Robin Vos, et al.
Antibiotics (Basel, Switzerland)|April 28, 2023
External Validation of the Augmented Renal Clearance Predictor in Critically Ill COVID-19 PatientsChao-Yuan Huang, Fabian Güiza, Matthias Gijsen, et al.
Pharmaceutics|November 11, 2022
Clinical Efficacy of Temocillin Standard Dosing in Patients Treated with Outpatient Antimicrobial TherapyEvelyne Van den Broucke, Lore Thijs, Stefanie Desmet, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 14, 2025
Correction to: Outpatient parenteral antibiotic therapy in non-cystic fibrosis lung transplant recipients: characteristics, efficacy and safetyBart Forier, Veronique Schaevers, Isabel Spriet, et al.
Mycoses|April 19, 2022
Exposure to intravenous posaconazole in critically ill patients with influenza: A pharmacokinetic analysis of the POSA-FLU studyRuth Van Daele, Joost Wauters, Erwin Dreesen, et al.
Mycoses|May 14, 2026
Impact of Concomitant Metamizole Treatment on the Exposure of Mould-Active TriazolesDorian Vanneste, Ine De Booser, Kristina Nadrah, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 28, 2024
Outpatient parenteral antibiotic therapy in non-cystic fibrosis lung transplant recipients: characteristics, efficacy and safetyBart Forier, Veronique Schaevers, Isabel Spriet, et al.
The Journal of Antimicrobial Chemotherapy|January 31, 2021
Pharmacokinetics and target attainment of intravenous posaconazole in critically ill patients during extracorporeal membrane oxygenationRuth Van Daele, Roger J Brüggemann, Erwin Dreesen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 7, 2018
Dose Reduction May Jeopardize Efficacy of Abiraterone AcetateF J Sherida H Woei-A-Jin, Tine Van Nieuwenhuyse, Nielka P van Erp, et al.
Pageof 24

Showing results (191-200 of 237) with videos related to

Sort By:
Pageof 24
Air Medical Journal|July 10, 2016
Stability of Drugs Used in Helicopter Air Medical Emergency Services: An Exploratory StudySabrina De Winter, Koen Bronselaer, Peter Vanbrabant, et al.
Mycoses|May 8, 2021
Concomitant use of isavuconazole and CYP3A4/5 inducers: Where pharmacogenetics meets pharmacokineticsRuth Van Daele, Yves Debaveye, Robin Vos, et al.
Antibiotics (Basel, Switzerland)|April 28, 2023
External Validation of the Augmented Renal Clearance Predictor in Critically Ill COVID-19 PatientsChao-Yuan Huang, Fabian Güiza, Matthias Gijsen, et al.
Pharmaceutics|November 11, 2022
Clinical Efficacy of Temocillin Standard Dosing in Patients Treated with Outpatient Antimicrobial TherapyEvelyne Van den Broucke, Lore Thijs, Stefanie Desmet, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 14, 2025
Correction to: Outpatient parenteral antibiotic therapy in non-cystic fibrosis lung transplant recipients: characteristics, efficacy and safetyBart Forier, Veronique Schaevers, Isabel Spriet, et al.
Mycoses|April 19, 2022
Exposure to intravenous posaconazole in critically ill patients with influenza: A pharmacokinetic analysis of the POSA-FLU studyRuth Van Daele, Joost Wauters, Erwin Dreesen, et al.
Mycoses|May 14, 2026
Impact of Concomitant Metamizole Treatment on the Exposure of Mould-Active TriazolesDorian Vanneste, Ine De Booser, Kristina Nadrah, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 28, 2024
Outpatient parenteral antibiotic therapy in non-cystic fibrosis lung transplant recipients: characteristics, efficacy and safetyBart Forier, Veronique Schaevers, Isabel Spriet, et al.
The Journal of Antimicrobial Chemotherapy|January 31, 2021
Pharmacokinetics and target attainment of intravenous posaconazole in critically ill patients during extracorporeal membrane oxygenationRuth Van Daele, Roger J Brüggemann, Erwin Dreesen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 7, 2018
Dose Reduction May Jeopardize Efficacy of Abiraterone AcetateF J Sherida H Woei-A-Jin, Tine Van Nieuwenhuyse, Nielka P van Erp, et al.
Pageof 24